DK127598B - Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.

Info

Publication number
DK127598B
DK127598B DK655269A DK655269A DK127598B DK 127598 B DK127598 B DK 127598B DK 655269 A DK655269 A DK 655269A DK 655269 A DK655269 A DK 655269A DK 127598 B DK127598 B DK 127598B
Authority
DK
Denmark
Prior art keywords
ethylgonenes
homogens
haloalkynyl
dihydroxy
ethers
Prior art date
Application number
DK655269A
Other languages
English (en)
Inventor
G Hughes
H Smith
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK448162AA external-priority patent/DK113641B/da
Priority claimed from GB3206463A external-priority patent/GB1100441A/en
Application filed by H Smith filed Critical H Smith
Priority to DK38273A priority Critical patent/DK131020B/da
Publication of DK127598B publication Critical patent/DK127598B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pressure-Spray And Ultrasonic-Wave- Spray Burners (AREA)
DK655269A 1962-10-17 1969-12-10 Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf. DK127598B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK38273A DK131020B (da) 1962-10-17 1973-01-24 Antikonceptionelt middel.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
GB3206463A GB1100441A (en) 1963-08-14 1963-08-14 13-alkyl 17-halogenoalkynyl-steroid 3-ketones and their derivatives
DK400464A DK134161B (da) 1962-10-17 1964-08-13 Analogifremgangsmåde til fremstilling af steroidketoner.

Publications (1)

Publication Number Publication Date
DK127598B true DK127598B (da) 1973-12-03

Family

ID=27221920

Family Applications (3)

Application Number Title Priority Date Filing Date
DK400464A DK134161B (da) 1961-10-19 1964-08-13 Analogifremgangsmåde til fremstilling af steroidketoner.
DK655269A DK127598B (da) 1962-10-17 1969-12-10 Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.
DK220272A DK127475B (da) 1962-10-17 1972-05-03 Analogifremgangsmåde til fremstilling af17-halogenalkynyl-17-hydroxy-13-ethylgonener eller -D-homogonener eller estere eller ethere deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK400464A DK134161B (da) 1961-10-19 1964-08-13 Analogifremgangsmåde til fremstilling af steroidketoner.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK220272A DK127475B (da) 1962-10-17 1972-05-03 Analogifremgangsmåde til fremstilling af17-halogenalkynyl-17-hydroxy-13-ethylgonener eller -D-homogonener eller estere eller ethere deraf.

Country Status (14)

Country Link
JP (1) JPS4837029B1 (da)
AT (3) AT301039B (da)
BE (1) BE651797A (da)
BR (1) BR6461643D0 (da)
CH (1) CH498819A (da)
DE (4) DE1468988B1 (da)
DK (3) DK134161B (da)
FR (2) FR1566154A (da)
GB (2) GB1100443A (da)
IL (1) IL21826A (da)
IN (2) IN95058B (da)
NL (2) NL139307B (da)
NO (3) NO126016B (da)
SE (5) SE331470B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2913381A1 (de) * 1979-03-30 1980-10-16 Schering Ag 11-methylensteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
JPS57106714U (da) * 1980-12-23 1982-07-01
DE3214689A1 (de) * 1982-04-16 1983-10-27 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-chlor-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
WO2012110947A1 (en) * 2011-02-17 2012-08-23 Lupin Limited An improved process for preparation of levonorgestrel

Also Published As

Publication number Publication date
DE1618871B2 (de) 1973-07-26
AT269376B (de) 1969-03-10
DE1618872C3 (de) 1974-10-24
NO127193B (da) 1973-05-21
DE1618871C3 (de) 1974-02-21
GB1100444A (en) 1968-01-24
AT301045B (de) 1972-08-25
DK134161C (da) 1977-02-21
DE1618872A1 (de) 1972-06-15
SE335120B (da) 1971-05-17
DE1793641C2 (de) 1973-12-20
SE335119B (da) 1971-05-17
AT301039B (de) 1972-08-25
CH498819A (de) 1970-11-15
BR6461643D0 (pt) 1973-08-09
DK134161B (da) 1976-09-20
SE350256B (da) 1972-10-23
FR1566154A (da) 1969-05-09
IN95058B (da) 1975-08-16
BE651797A (da)
NL139307B (nl) 1973-07-16
SE331470B (da) 1971-01-04
DE1468988B1 (de) 1971-11-25
IL21826A (en) 1968-12-26
DK127475B (da) 1973-11-12
FR4915M (da) 1967-03-20
GB1100443A (en) 1968-01-24
NL7308508A (da) 1973-09-25
DE1793641B1 (de) 1973-05-24
DE1618871A1 (de) 1972-08-10
JPS4837029B1 (da) 1973-11-08
DE1618872B2 (de) 1974-03-07
NO129905B (da) 1974-06-10
NL6409391A (da) 1965-02-15
IN137555B (da) 1975-08-16
NO126016B (da) 1972-12-11
SE334879B (da) 1971-05-10

Similar Documents

Publication Publication Date Title
DK115403B (da) Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.
DK119925B (da) Analogifremgangsmåde til fremstilling af 3,17β-dihydroxy-11β-alkyloxy-13β-alkylgona-1,3,5(10)-triener eller ethere eller estere deraf.
DK127062B (da) Analogifremgangsmåde til fremstilling af 18-nor-13β-ethyl-estradiol eller dets estere.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK104232C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-Δ<4,9,11>-estratrien eller dets estere.
DK127598B (da) Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.
DK116501B (da) Fremgangsmåde til fremstilling af polysaccharider eller estere eller ethere deraf.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK104303C (da) Fremgangsmåde til fremstilling af 3α-hydroxy-11-oxo-21,21-bis-(hydroxymethyl)-5β-pregnan eller estere deraf.
DK130835B (da) Fremgangsmåde til fremstilling af 3-oxo-7alfa-methyl-13beta-alkyl-17beta-hydroxy-gona-4,11-diener eller estere eller ethere deraf.
DK109561C (da) Fremgangsmåde til fremstilling af 3,16β-dihydroxy-16α-ethinyl-1,3,5(10)-estratrien eller ethere eller estere heraf.
DK107162C (da) Fremgangsmåde til fremstilling af 3-enol-ethere af 2-formyl-3-oxo-5α-steroider.
DK102858C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-10β-allyl-Δ<4,9(11)>-estradien eller dets estere.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK100727C (da) Fremgangsmåde til fremstilling af 9α,10α-epoxy-2α-methyl-19-nor-testostreroner eller estere eller ethere heraf.
DK107609C (da) Fremgangsmåde til fremstilling af 1α-hydroxy-3-keto-androstanforbindelser eller estere eller ethere deraf.
DK117628B (da) Analogifremgangsmåde til fremstilling af ethere eller thioethere.
DK117561B (da) Fremgangsmåde til fremstilling af 2-oxo-A-nor-estra-3(5),9,11-trien-17β-ol eller estere eller ethere deraf.
DK100368C (da) Fremgangsmåde til fremstilling af 9β-estradiol eller estere eller ethere heraf.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK106091C (da) Fremgangsmåde til fremstilling af 17α-alkyl-17β-hydroxy-2-azaandrostan-3-oner eller 17α-alkyl-17β-hydroxy-3-aza-A-homoandrostan-4-oner.
DK120188B (da) Fremgangsmåde til fremstilling af 3-oxo-17α-methyl-17β-hydroxy-A-nor-B-homo-østraner eller estere eller ethere deraf eller 1-dehydroderivater deraf.
DK115914B (da) Analogifremgangsmåde til fremstilling af 2-oxo-17β-hydroxy-A-norestra-3,9,11-trien eller estere eller ethere deraf.